Clinical trial
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197
Study timeline
Study start (actual)2023-10-12Date precision: day
Registry last updated2025-02-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
NMDAEDRUG
Placebo CapDRUG
Sponsors & collaborators
China Medical University Hospitallead sponsor
National Science and Technology Council, Taiwancollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06021197 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.